Concepedia

Publication | Closed Access

Efficacy and Safety of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients

DOI

108

Citations

40

References

2019

Year

Madhav Prasad Yadav, Sanjana Ballal, Chandrasekhar Bal, Ranjit Kumar Sahoo, Madhavi Tripathi, Amlesh Seth
Clinical Nuclear Medicine

Abstract

Lu-PSMA-617 radionuclide therapy is a safe and effective approach to the treatment of mCRPC patients.

References

YearCitations

Page 1